Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Chrisanthi H. Mitsouli"'
Autor:
E. Grigoriou, Nikolaos Harhalakis, John Apostolidis, Themistokles Karmiris, E. Spanou, J. Baltadakis, Chrisanthi H. Mitsouli, Dimitri Karakasis, Maria Bakiri, M. Tsantekidou, H. Mihalakeas, Maria Pagoni, Emmanuel Nikiforakis
Publikováno v:
Leukemia & Lymphoma. 44:1523-1528
The current management of early stage Hodgkin's disease (HD) is usually based on clinical staging, combined modality therapy and the use of less toxic chemotherapy regimens. This approach entails high cure rates, while ensures less long term toxicity
Autor:
Demitris Kousiafes, Emmanuel Nikiforakis, John Apostolidis, Nikolaos Harhalakis, Themis Karmiris, Marina Tsandekidi, Chrisanthi H. Mitsouli, Demitris Karakasis, Maria Pagoni, Maria Bakiri
Publikováno v:
Blood. 98:2875-2877
In a recent report on adults with idiopathic thrombocytopenic purpura (ITP), Portielje et al[1][1] presented limited data on the morbidity and mortality attributed to the systemic effects of short-course corticosteroids in the context of initial trea
Autor:
Anastasia Pouli, Dimitra Mihou, Panagiotis Zikos, Nikolaos Anagnostopoulos, Chrisanthi H. Mitsouli, Athanasios Anagnostopoulos, Marie-Christine Kyrtsonis, Evangelos Terpos, Irini Katodritou, Meletios A. Dimopoulos, Konstantinos Zervas, Souzana Delimbasi
Publikováno v:
Blood. 108:794-794
Introduction: VAD-doxil and VAD-doxil plus thalidomide have already been separately evaluated, as initial cytoreductive treatment in multiple myeloma, in two previous clinical trials of our study group. Both regimens proved effective yielding overall